Passive

Vanguard Health Care Index Fund

Vanguard Health Care Index Fund (the “Fund”) seeks to track the performance of a benchmark index that measures the investment return of health care stocks.

$173.23

Key Metrics

TER 0.09% per year
Distribution policy Distributing
Fund size USD 22,044 M
Inception date February 5, 2004
Holdings 423
Fund currency USD
Fund domicile US
Provider Vanguard
For full official fund details, factsheets, and holdings, visit investor.vanguard.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Health Care Index Fund VHCIX
Fund Size
$22B
Dividend
1.3%
Fees
0.09%
Morningstar Total Stock Market Index Fund VSMPX
Fund Size
$2.3T
Dividend
1.1%
Fees
0.02%
Morningstar Total Stock Market Index Fund VTSAX
Fund Size
$2.3T
Dividend
1.1%
Fees
0.04%
Morningstar Total Stock Market Index Fund VTI
Fund Size
$2.3T
Dividend
1.1%
Fees
0.03%
Morningstar Total Stock Market Index Fund VITSX
Fund Size
$2.3T
Dividend
1.1%
Fees
0.03%
View 1342 similar ETFs →

Historical Return

Last updated: Nov 01, 2026
1 Year +8.6% +1.3% Div
3 Years (avg.) +2.8% +1.3% Div
5 Years (avg.) +1.7% +1.3% Div

Risk & Analysis Metrics

Last updated: Nov 01, 2026

Volatility

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Max Drawdown

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Sharpe Ratio

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Distributions

*by ETF Portfolio Weight Last updated: Nov 01, 2026

Profit Margin Distribution

< 0%
8%
1y 3y N/A N/A
0 - 5%
23%
1y 3y N/A N/A
5 - 10%
14%
1y 3y N/A N/A
10 - 15%
9%
1y 3y N/A N/A
15 - 20%
18%
1y 3y N/A N/A
20 - 30%
10%
1y 3y N/A N/A
30 - 40%
17%
1y 3y N/A N/A
> 40%
1%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
9%
1y 3y N/A N/A
0 - 10
1%
1y 3y N/A N/A
10 - 15
4%
1y 3y N/A N/A
15 - 20
5%
1y 3y N/A N/A
20 - 25
12%
1y 3y N/A N/A
25 - 35
12%
1y 3y N/A N/A
35 - 50
38%
1y 3y N/A N/A
> 50
20%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.2%
1y 3y N/A N/A
Small Cap
1.6%
1y 3y N/A N/A
Mid Cap
5.8%
1y 3y N/A N/A
Large Cap
37.8%
1y 3y N/A N/A
Mega Cap
54.6%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Nov 01, 2026
39.7% Top 5 Holdings
53.2% Top 10 Holdings
86.3% Top 50 Holdings
94.0% Top 100 Holdings
Top 5 Companies
LLY Lilly(Eli) & Co
14.4%
JNJ Johnson & Johnson
8.7%
ABBV Abbvie Inc
6.2%
UNH Unitedhealth Group Inc
5.6%
MRK Merck & Co Inc
4.8%

Latest News

16 days ago • businesswire.com

Lost Money on Merck & Co., Inc. Shares? The Law Offices of Frank R.

LOS ANGELES--(BUSINESS WIRE)--Merck & Co., Inc. ("Merck" or the "Company") investors who lost money may have claims to recover their losses. The La...
16 days ago • fool.com

Merck Lifts Outlook on a Lower Tax Rate: Rapid Earnings Reaction

Newer drugs are scaling fast enough to offset generic losses. Merck's third-quarter sales rose 5% to about $18.1 billion, but roughly $550 million ...
16 days ago • seekingalpha.com

Merck & Co., Inc. (MRK) Q3 2026 Earnings Call Transcript

Merck & Co., Inc. (MRK) Q3 2026 Earnings Call Transcript

Sectors

Manufacturing 71.2%
Finance and Insurance 8.0%
Professional, Scientific, and Technical Services 5.6%
Health Care and Social Assistance 4.4%
Wholesale Trade 3.2%
Retail Trade 1.7%
Healthcare 1.4%
Information 0.1%
Construction 0.0%
Financial Services 0.0%
Health Technology 0.0%
Other 4.3%

Countries

United States 100.0%

Stock Screener

Select filters to narrow down the 388 investments below

388 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
P/E Ratio
Dividends Ratio of dividends in the last 12 months to current share price
Total Investment
Weight

Lilly(Eli) & Co

LLY - Manufacturing

Lilly(Eli) & Co

LLY - Manufacturing
Market Cap $1.77T
P/E Ratio 46.7
Dividends 0.5%
Total Investment $2.84B
Weight 12.87%

Loading details…

Johnson & Johnson

JNJ - Manufacturing

Johnson & Johnson

JNJ - Manufacturing
Market Cap $900.36B
P/E Ratio 43.3
Dividends 1.8%
Total Investment $1.93B
Weight 8.75%

Loading details…

Abbvie Inc

ABBV - Manufacturing

Abbvie Inc

ABBV - Manufacturing
Market Cap $72.15B
P/E Ratio 50.6
Dividends 2.3%
Total Investment $1.38B
Weight 6.28%

Loading details…

Merck & Co Inc

MRK - Manufacturing

Merck & Co Inc

MRK - Manufacturing
Market Cap $80.8B
P/E Ratio 149.3
Dividends 2.3%
Total Investment $1.12B
Weight 5.06%

Loading details…

Unitedhealth Group Inc

UNH - Finance and Insurance

Unitedhealth Group Inc

UNH - Finance and Insurance
Market Cap $474.69B
P/E Ratio 23.3
Dividends 2.2%
Total Investment $1.08B
Weight 4.90%

Loading details…

AMGEN Inc.

AMGN - Manufacturing

AMGEN Inc.

AMGN - Manufacturing
Market Cap $227.99B
P/E Ratio 26.8
Dividends 2.1%
Total Investment $707.5M
Weight 3.21%

Loading details…

Thermo Fisher Scientific Inc.

TMO - Professional, Scientific, and Technical Services

Thermo Fisher Scientific Inc.

TMO - Professional, Scientific, and Technical Services
Market Cap $233.5B
P/E Ratio 36.9
Dividends 0.3%
Total Investment $700.15M
Weight 3.18%

Loading details…

Abbott Laboratories

ABT - Manufacturing

Abbott Laboratories

ABT - Manufacturing
Market Cap $32.69B
P/E Ratio 40.2
Dividends 2.3%
Total Investment $586.81M
Weight 2.66%

Loading details…

Gilead Sciences, Inc.

GILD - Manufacturing

Gilead Sciences, Inc.

GILD - Manufacturing
Market Cap $189.18B
P/E Ratio -54.2
Dividends 1.9%
Total Investment $554.58M
Weight 2.52%

Loading details…

Pfizer Inc.

PFE - Manufacturing

Pfizer Inc.

PFE - Manufacturing
Market Cap $213.47B
P/E Ratio 40.9
Dividends 6.0%
Total Investment $494.3M
Weight 2.24%

Loading details…

Vertex Pharmaceuticals, Inc.

VRTX - Manufacturing

Vertex Pharmaceuticals, Inc.

VRTX - Manufacturing
Market Cap $123.52B
P/E Ratio 34.4
Dividends 0.0%
Total Investment $422.89M
Weight 1.92%

Loading details…

Bristol-Myers Squibb Co.

BMY - Manufacturing

Bristol-Myers Squibb Co.

BMY - Manufacturing
Market Cap $814.59B
P/E Ratio 14.0
Dividends 4.0%
Total Investment $416.5M
Weight 1.89%

Loading details…

Danaher Corp.

DHR - Manufacturing

Danaher Corp.

DHR - Manufacturing
Market Cap $916.76B
P/E Ratio 38.1
Dividends 0.7%
Total Investment $415.29M
Weight 1.88%

Loading details…

Intuitive Surgical Inc

ISRG - Manufacturing

Intuitive Surgical Inc

ISRG - Manufacturing
Market Cap $7.93B
P/E Ratio 53.0
Dividends 0.0%
Total Investment $408.7M
Weight 1.85%

Loading details…

CVS Health Corp

CVS - Retail Trade

CVS Health Corp

CVS - Retail Trade
Market Cap $27.22B
P/E Ratio 10.3
Dividends 3.0%
Total Investment $364.78M
Weight 1.65%

Loading details…

Stryker Corp.

SYK - Manufacturing

Stryker Corp.

SYK - Manufacturing
Market Cap $7.92B
P/E Ratio 32.8
Dividends 1.1%
Total Investment $340.76M
Weight 1.55%

Loading details…

Mckesson Corporation

MCK - Wholesale Trade

Mckesson Corporation

MCK - Wholesale Trade
Market Cap $126.43B
P/E Ratio 28.2
Dividends 0.3%
Total Investment $331.07M
Weight 1.50%

Loading details…

Anthem Inc

ANTM - Finance and Insurance

Anthem Inc

ANTM - Finance and Insurance
Market Cap $91.5B
P/E Ratio 18.3
Dividends 1.6%
Total Investment $255.82M
Weight 1.16%

Loading details…

Regeneron Pharmaceuticals, Inc.

REGN - Manufacturing

Regeneron Pharmaceuticals, Inc.

REGN - Manufacturing
Market Cap $97.44B
P/E Ratio 20.4
Dividends 0.4%
Total Investment $253.51M
Weight 1.15%

Loading details…

Cigna Group (The)

CI - Finance and Insurance

Cigna Group (The)

CI - Finance and Insurance
Market Cap $70.66B
P/E Ratio 13.1
Dividends 2.1%
Total Investment $222.26M
Weight 1.01%

Loading details…